^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

ER positive

i
Other names: ESR1, Era, ESR, NR3A1, ER, ER beta
Entrez ID:
9ms
Clinical • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • HER-2 negative • EGFR positive
|
amcenestrant (SAR439859)
10ms
Clinical • Video • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • HER-2 negative
|
Ibrance (palbociclib)
10ms
Clinical • Liquid biopsy
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • HER-2 negative • ER mutation • ESR1 mutation
11ms
Review
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • HER-2 negative • ER positive + HER-2 negative
1year
FDA event • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • HER-2 negative • ER mutation • ESR1 mutation
|
Orserdu (elacestrant)
1year
Clinical • Next-generation sequencing
|
ER (Estrogen receptor)
|
ER positive
|
Guardant360® CDx
1year
Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • HER-2 negative • ER mutation • ESR1 mutation
|
Orserdu (elacestrant)
1year
FDA event • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • HER-2 negative • ER mutation • ESR1 mutation
|
Orserdu (elacestrant)
1year
Clinical • FDA event • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • HER-2 negative
|
Orserdu (elacestrant)
1year
FDA event • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
ER positive • HER-2 negative • ER mutation • ESR1 mutation
|
Orserdu (elacestrant)
1year
ER (Estrogen receptor) • PD-L2 (Programmed Cell Death 1 Ligand 2)
|
ER positive
1year
Clinical • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
HER-2 positive • ER positive • HER-2 negative • ER positive + HER-2 negative
|
Orserdu (elacestrant)
over1year
Clinical • P3 data
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
HER-2 positive • ER positive • HER-2 negative • ER positive + HER-2 negative